Ieramilimab (Anti-LAG3 / CD223)

Ieramilimab (Anti-LAG3 / CD223) is a humanized IgG4 monoclonal antibody that targets LAG-3. It has antitumor activity and can be used in treatment of advanced malignancies MW :146.78 KD.

• Supplier: Selleck Chemicals
• Product #: A2996
• Sku #: A2996-1mg